China NMPA Drug Inspection - Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. - Magnolia officinalis
China NMPA drug inspection for Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. published January 22, 2020. Drug: Magnolia officinalis. The Ningxia Drug Administration, operating under China's National Medical Products Administration, published an announce
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. published January 22, 2020. Drug: Magnolia officinalis. The Ningxia Drug Administration, operating under China's National Medical Products Administration, published an announce
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox